-
EP2322159
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2322159
| EP2322159 - Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 27.04.2012 Database last updated on 07.06.2024 | Most recent event Tooltip | 27.04.2012 | Application deemed to be withdrawn | published on 30.05.2012 [2012/22] | Applicant(s) | For all designated states Green Molecular, S.L. Parc Cientific de la Universitat de Valencia Poligono La Coma s/n. Despacho No 7 46980 Valencia / ES | [2011/20] | Inventor(s) | 01 /
Jose María, Estrela Ariquel Green Molecular S.L Parc Cientific de la Universit 46980, Valencia / ES | 02 /
Miguel A., Asensi Miralles Green Molecular S.A. Parc Cientific de la Universi 46980, Valencia / ES | [2011/20] | Representative(s) | Illescas, Manuel GONZÁLEZ-BUENO & ILLESCAS Calle de Recoletos, 13 - 5 lzq. 28001 Madrid / ES | [N/P] |
| Former [2011/20] | Illescas, Manuel GONZÁLEZ-BUENO & ILLESCAS Calle de Recoletos, 13 - 5 lzq. 28001 Madrid / ES | Application number, filing date | 09174717.0 | 30.10.2009 | [2011/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2322159 | Date: | 18.05.2011 | Language: | EN | [2011/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 28.07.2010 | Classification | IPC: | A61K31/05 | [2011/20] | CPC: |
A61K31/09 (EP,US);
C07C43/166 (KR);
A61K31/352 (EP,US);
A61K31/353 (US);
A61K8/14 (EP,US);
A61K8/347 (EP,US);
A61K8/498 (EP,US);
A61K9/0014 (EP,KR,US);
A61K9/127 (EP,KR,US);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P17/16 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61Q17/04 (US);
A61Q19/00 (EP,KR,US);
C07D311/30 (KR);
A61K2800/74 (US)
(-)
| C-Set: |
A61K31/09, A61K2300/00 (EP,US);
A61K31/352, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/20] | Title | German: | Verwendung von Pterostilben (PTER) als Medikament zur Vorbeugung und/oder Behandlung von Hauterkrankungen, -schädigungen oder Verletzungen oder als Kosmetikmittel | [2011/20] | English: | Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic | [2011/20] | French: | Utilisation de pterostilbene (pter) en tant que médicament pour la prévention et/ou le traitement des maladies de la peau, dommages ou blessures ou en tant que cosmétiques | [2011/20] | Examination procedure | deleted | Communication of intention to grant the patent | 15.01.2010 | Loss of particular rights, legal effect: Claims | 23.02.2010 | Despatch of communication of loss of particular rights: Claims {1} | 19.11.2011 | Application deemed to be withdrawn, date of legal effect [2012/22] | 16.01.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2012/22] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.10.2011 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0143705 (JOHNSON & JOHNSON CONSUMER [US]) [X] 1-19* page 4, lines 14-15 - page 10, lines 27-33; claim 1 *; | [I]WO03049713 (DRAGOCO GERBERDING CO AG [DE], et al) [I] 1-19 * page 12, paragraph 3; compound formula 1 *; | [A]EP1782802 (UNIV VALENCIA [ES]) [A] 1-19 * example 2 *; | [A]US2009163580 (YATCILLA MICHAEL TODD [US], et al) [A] 1-19 * claim 2 *; | [A] - FERRER P ET AL, "Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma", NEOPLASIA, NEOPLASIA PRESS, ANN ARBOR, MI, US LNKD- DOI:10.1593/NEO.04337, (20050101), vol. 7, no. 1, ISSN 1522-8002, pages 37 - 47, XP003018478 [A] 1-12 * "Results" * DOI: http://dx.doi.org/10.1593/neo.04337 | [A] - ORTEGA A ET AL, "INHIBITION OF B16 MELANOMA GROWTH AND METASTATIC ACTIVITY BY COMBINED ADMINISTRATION OF PTEROSTILBENE AND QUERCETIN", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20040301), vol. 45, ISSN 0197-016X, page 883, XP001536815 [A] 1-19 * abstract * | by applicant | WO2008067928 | - JANG M ET AL., SCIENCE, (1997), vol. 275, no. 5297, pages 218 - 20 | - ASENSI M ET AL., FREE ADIC BIOL MED., (2002), vol. 33, no. 3, pages 387 - 98 | - FERRER P ET AL., NEOPLASIA., (2005), vol. 7, no. 1, pages 37 - 47 | - PRIEGO S ET AL., MOL CANCER THER., (2008), vol. 7, no. 10, pages 3330 - 42 | - RUBIA CASAGRANDE ET AL., J. PHOTOCHEM PHOTOBIOL B: BIOLOGY, (2006), vol. 84, pages 21 - 27 | - ALENA SVOBODOVá; JITKA PSOTOVá; DANIELA WALTEROVá, BIOMED. PAPERS, (2003), vol. 147, no. 2, pages 137 - 145 | - MOAMMIR HASAN AZIZ ET AL., FASEB J., (2005), pages 1 - 18 |